Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Tianxin Pharmaceutical is a China-based commercial pharmaceutical and nutrition ingredients company focused on the research, development, manufacturing, and sale of monomeric vitamins and related fine chemicals. The company is best known for large-scale production of vitamin APIs and ingredients including vitamin B1, vitamin B6, biotin, folic acid, vitamin D3, and ascorbyl palmitate for use in pharmaceutical, food, and feed applications. It operates primarily as a manufacturing-led business rather than a clinical-stage drug developer, with capabilities centered on process technology, quality systems, and global supply of vitamin products. Although the query references "DSM Tianxin Pharmaceutical," the exact current entity appears to be Jiangxi Tianxin Pharmaceutical, an independent listed Chinese company rather than a DSM subsidiary. The business is active and commercially oriented, with products already on the market rather than a traditional therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DSM Tianxin Pharmaceutical.